VirtualIncisionPortfolio

Grand Rapids, Mich., May 22, 2023— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Lincoln, Nebraska-based Virtual Incision Corporation, has submitted a De Novo request to the U.S. Food and Drug Administration (FDA) to market its MIRA Surgical

FDA decision supported by an interim clinical study report on patient safety Grand Rapids, Mich., February 28, 2023— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Lincoln, Nebraska-based Virtual Incision Corporation, has completed its U.S. Food and Drug

FDA decision supported by an interim clinical study report on patient safety Lincoln, Neb. – April 19, 2022 – Virtual Incision Corporation, a medical device company pioneering the world’s first miniaturized robotic-assisted surgery (RAS) platform, today announced the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) supplement to complete the

Grand Rapids, MI. – December 1st, 2021 – Genesis Innovation Group’s cultivate(MD) Capital Funds announces that one of their portfolio companies, Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery, has raised $46 million in a Series C funding round. The round was led by Endeavour Vision and Baird Capital, with significant

Company Begins IDE Study, Advancing Goal of Bringing Robotically Assisted Surgery to Any U.S. Hospital or Ambulatory Surgery Center

Company Prepares MIRA for Use in Minimally-Invasive Laparoscopic Colon Surgery

HOLLAND, Mich., Jan. 13, 2020 PRNewswire — Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces its participation in Virtual Incision Corporation’s raise of $20 million in Series B+ financing. Virtual Incision is a medical device company pioneering the first-of-its-kind, miniaturized surgical robot and the